Thieler Law Corp advises investors with losses exceeding $100,000 of the July 5, 2016 lead plaintiff deadline in a class action lawsuit filed against Express Scripts Holding Company (NASDAQ:ESRX) (“Express Scripts” or “the Company”). The suit is pending in the U.S. District Court for the Southern District of New York and investors, who purchased Express Scripts securities between February 24, 2015 to March 21, 2016, have until July 5, 2016 to move for lead plaintiff. You do not need to move for lead plaintiff to be a member of the Class.

If you purchased Express Scripts securities during the Class Period, and have losses over $100,000, you may contact Thieler Law Corp by calling at (619) 377 - 4324 or emailing mail@thielerlaw.com . No class has been certified in this case, and if your losses are less than $100,000 you are still a member of the class.

The Complaint alleges that during the Class Period, Defendants violated provisions of the Exchange Act by issuing false and misleading press releases, financial statements, filings with the U.S. Securities and Exchange Commission and statements during investor conference calls. 

Throughout the Class Period Express Scripts failed to disclose and/or misled investors as to the true state of the Company's relationship and contract with client Anthem Inc. Express Scripts constantly assured investors that its relationship with Anthem remained strong and that it was providing Anthem, and all of its customers, with high quality service.  Also, Express Scripts addressed the ongoing drug pricing negotiations with Anthem, stating that Express Scripts was committed to reaching a mutually beneficial agreement, and continuing its successful working relationship with its most important client.

On January 12, 2016, Anthem threatened to terminate its relationship with Express Scripts unless it renegotiated an agreement that would deliver more than $3 billion in annual savings to Anthem.

Then on March 21, 2016, Anthem took legal action against Express Scripts, alleging that the Company breached its contract by failing to negotiate drug pricing terms in good faith. The complaint revealed a conflict between Express Scripts and Anthem dating back to at least February 2015.

Following this news, Express Scripts shares declined causing investors harm.

If you were negatively impacted by your investment in Express Scripts securities between February 24, 2015 to March 21, 2016 and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, please contact us for your no-cost evaluation.

Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/

or

Facsimile: +1 (619) 785 – 3185